BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 24395443)

  • 1. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
    Reinemann C; Strehlitz B
    Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of aptamers in cancer research: an up-to-date review.
    Hu M; Zhang K
    Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-aptamer conjugates for cancer cell targeting and detection.
    Estévez MC; Huang YF; Kang H; O'Donoghue MB; Bamrungsap S; Yan J; Chen X; Tan W
    Methods Mol Biol; 2010; 624():235-48. PubMed ID: 20217600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in aptamer selection methods and applications.
    Yüce M; Ullah N; Budak H
    Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers: a promising tool for cancer imaging, diagnosis, and therapy.
    Liu K; Lin B; Lan X
    J Cell Biochem; 2013 Feb; 114(2):250-5. PubMed ID: 22949372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress of aptamers application in molecular imaging].
    Ye Q; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1230-4. PubMed ID: 23469563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers and SELEX in Chemistry & Biology.
    Famulok M; Mayer G
    Chem Biol; 2014 Sep; 21(9):1055-8. PubMed ID: 25237853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aptamers in clinical diagnostics].
    Szpechciński A; Grzanka A
    Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing trends in aptamer-based biosensor devices and their applications.
    MacKay S; Wishart D; Xing JZ; Chen J
    IEEE Trans Biomed Circuits Syst; 2014 Feb; 8(1):4-14. PubMed ID: 24681915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-conjugated gold nanoparticles for bioanalysis.
    Zhang J; Liu B; Liu H; Zhang X; Tan W
    Nanomedicine (Lond); 2013 Jun; 8(6):983-93. PubMed ID: 23730697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric aptamers in cancer cell-targeted drug delivery.
    Kanwar JR; Roy K; Kanwar RK
    Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamers: molecular tools for medical diagnosis.
    Ozalp VC; Kavruk M; Dilek O; Bayrac AT
    Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers used for biosensors and targeted therapy.
    Ning Y; Hu J; Lu F
    Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.